The levels of LDLR downregulation will lead to the increase of circulating LDL and neuroinflammation in Alzheimer's disease models, while as the potential targets of statins in ischemic stroke, the decrease of LDLR could be inhibited by statin treatment [24]. Here, LDLR is linked to Alzheimer disease.